These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 1138203)

  • 1. Effects of oestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cells.
    Lloyd HM; Meares JD; Jacobi J
    Nature; 1975 Jun; 255(5508):497-8. PubMed ID: 1138203
    [No Abstract]   [Full Text] [Related]  

  • 2. Early effects of stilboestrol on growth hormone and prolactin secretion and on pituitary mitotic activity in the male rat.
    Lloyd HM; Meares JD; Jacobi J
    J Endocrinol; 1973 Aug; 58(2):227-31. PubMed ID: 4726322
    [No Abstract]   [Full Text] [Related]  

  • 3. Secretory and mitotic response of the male rat pituitary gland to repeated doses of oestrogen.
    Lloyd HM; Meares JD; Jacobi J
    Int J Cancer; 1973 Jan; 11(1):90-4. PubMed ID: 4790838
    [No Abstract]   [Full Text] [Related]  

  • 4. DNA synthesis and depletion of prolactin in the pituitary gland of the male rat.
    Lloyd HM; Jacobi JM; Meares JD
    J Endocrinol; 1978 Apr; 77(1):129-36. PubMed ID: 641429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of dopamine, bromocriptine, lergotrile and metoclopramide on prolactin release from continuously perfused columns of isolated rat pituitary cells.
    Yeo T; Thorner MO; Jones A; Lowry PJ; Besser GM
    Clin Endocrinol (Oxf); 1979 Feb; 10(2):123-30. PubMed ID: 34491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration and nature of altered pituitary function in the male rat after a single large dose of estrogen.
    Lloyd HM; Meares JD; Thomas FJ
    Horm Metab Res; 1972 Sep; 4(5):392-5. PubMed ID: 4645937
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of the effects of CB-154 and lergotrile mesylate on prolactin and growth hormone secretion in mice.
    Sinha YN; Salocks CB; VanderLaan WP
    Horm Metab Res; 1976 Sep; 8(5):332-6. PubMed ID: 989755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA synthesis and the secretion of prolactin and growth hormone by the pituitary gland of the male rat: effects of diethylstilboestrol and 2-bromo-alpha-ergocryptine methanesluphonate.
    Davies C; Jacobi J; Lloyd HM; Meares JD
    J Endocrinol; 1974 Jun; 61(3):411-7. PubMed ID: 4366118
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of prolactin inhibitory agents on the ectopic anterior pituitary and the mammary gland in rats.
    Gräf KJ; Horowski R; Etreby MF
    Acta Endocrinol (Copenh); 1977 Jun; 85(2):267-78. PubMed ID: 325978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulatory effect of the dopa-decarboxylase inhibitor Ro 4-4602 on prolactin release; inhibition by l-dopa, metergoline, methysergide and 2-Br-alpha-ergocryptine.
    Pontiroli AE; Castegnaro E; Vettaro MP; Viberti GC; Pozza G
    Acta Endocrinol (Copenh); 1977 Jan; 84(1):36-44. PubMed ID: 318788
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of mesulergine on prolactin secretion and anterior pituitary cells morphology in diethylstilboestrol-treated female Wistar rats.
    Pisarek H; Stepien H
    Histol Histopathol; 1992 Jan; 7(1):111-7. PubMed ID: 1576426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic modulation of the diethylstilbestrol-induced proliferation of the anterior pituitary gland of the Fisher 344 rat.
    Miyazaki K; Dambrosia JM; Kebabian JW
    Neuroendocrinology; 1985 Nov; 41(5):405-8. PubMed ID: 2932654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of mesulergine on prolactin secretion and dopamine D2 receptors-adaptive changes in diethylstilbestrol-induced hyperplasia of the rat anterior pituitary.
    Pisarek H; Stepien H; Pawlikowski M
    Endocr Regul; 1992 Mar; 26(1):17-22. PubMed ID: 1421203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonally induced renal neoplasia in the male Syrian hamster and the inhibitory effect of 2-bromo-alpha-ergocryptine methanesulfonate.
    Hamilton JM; Flaks A; Saluja PG; Maguire S
    J Natl Cancer Inst; 1975 Jun; 54(6):1385-400. PubMed ID: 166190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of the dopamine agonist, lergotrile mesylate, on prolactin secretion in women.
    Leebaw W; Lee L; Woolf P
    Acta Endocrinol (Copenh); 1978 Jan; 87(1):12-8. PubMed ID: 579527
    [No Abstract]   [Full Text] [Related]  

  • 16. Growth hormone and prolactin content of hyperplastic anterior pituitary of dehydroepiandrosterone treated rats.
    Halmy L; Nagy I; Kurcz M
    Endokrinologie; 1975 Dec; 66(3):241-9. PubMed ID: 129325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum prolactin levels of rats under continuous estrogen stimulation and 2 Br-alpha-ergocryptine (CB-154) injection.
    Gala RR; Boss RS
    Proc Soc Exp Biol Med; 1975 Jun; 149(2):330-2. PubMed ID: 1153405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of bromocryptine on the secretion of thyrotropic hormone (TSH), prolactin (Pr), human growth hormone (HGH), thyroxine (T4) and triiodothyroxine (T3) in hypothyroidism.
    Felt V; Nedvdková J
    Horm Metab Res; 1977 Jul; 9(4):274-7. PubMed ID: 408253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of DNA in oestrogen-induced pituitary tumurs in rats: effect of bromocriptine.
    Kalbermann LE; Machiavelli GA; De Nicola AF; Weissenberg LS; Burdman JA
    J Endocrinol; 1980 Nov; 87(2):221-4. PubMed ID: 7430920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible involvement of dopamine in the release of prolactin-like hormone from bullfrog pituitary gland.
    Kikuyama S; Seki T
    Gen Comp Endocrinol; 1980 Jun; 41(2):173-9. PubMed ID: 6968286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.